Tagactac, Placidad D.

HRN: 24-18-70  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
12/07/2023
AMPICILLIN 1GM + SULBACTAM 500MG (VIAL)
12/07/2023
12/13/2023
IVT
1.5g
Q6
Herpes Zoster Ophthalmicus; Soft Tissue Infection
Checking Final Appropriateness 

Indication:  Empiric    Type of Infection:  Skin & Soft Tissue    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Intervention



Type of Intervention done:

                    

           


Acceptance: